Weill Cornell Medicine has secured an $11.6 million, five-year grant from the National Institute on Drug Abuse (NIDA) to explore the impact of cannabis, including marijuana...
As a concerned individual searching for credible evidence linking cannabis use to psychosis, I recently came across an intriguing article on the NIDA website. This article,...
In a recent study, cannabis users have been found to exhibit significantly higher levels of lead and cadmium in their blood and urine, raising concerns about...
Cannabis legalization has been a subject of debate and discussion for years, with proponents highlighting potential economic benefits and proponents raising concerns about public safety. One...
In May 2022, The American Council on Science and Health published an insightful interview conducted by Josh Bloom with Dr. Roneet Lev, the founder of the...
Researchers in Australia are embarking on a groundbreaking investigation into the potential economic benefits of medicinal cannabis as a treatment for chronic health conditions. This study,...
In a groundbreaking discovery, researchers in Brazil have found cannabidiol (CBD) in the fruits and flowers of a common Brazilian plant. What makes this discovery even...
Inflammatory Bowel Disease (IBD) is a chronic and often debilitating condition that affects millions of individuals worldwide. Managing the symptoms and achieving remission in IBD patients...
The buzz around cannabis as a potential medical marvel continues, with recent research diving into its potential to tame the unruly tics of Tourette's syndrome....
Leading Canadian cannabis producer, MediPharm Labs, has achieved a significant milestone by completing the shipment of a cannabis oil formulation containing both CBD and THC to...
In a groundbreaking development, Celadon Pharmaceuticals, a company specializing in cannabis-based therapies, has secured approval from the NHS Research Ethics Committee for its private pain clinic,...
Yes, preliminary evidence from laboratory studies indicate that CBD may shrink some tumors especially those related to melanomas, glioblastomas (GBM), breast, lung, prostate and colon cancer....
On April 15th, 2023, Releaf conducted a comprehensive online survey among a nationally representative sample of UK adults to gain insights into the use and perceptions...
During a recent outreach event in St. Louis, Abigail Vivas, the chief equity officer with the Missouri Department of Health and Senior Services, publicly pledged to...
The landscape surrounding cannabis research is a complex and intricate one, primarily due to its classification as a scheduled substance by the U.S. Drug Enforcement Administration...